Mr. Steve Saviuk reports

VALEO PHARMA ANNOUNCES NEW BOARD APPOINTMENTS

Tamara Close and Didier Leconte have joined Valeo Pharma Inc.'s board of directors. Following the appointment of Ms. Close and Mr. Leconte, Valeo's board of directors now comprises eight directors, five of whom are independent.

"We are pleased to welcome Tamara and Didier to the Valeo board of directors. Their extensive and diverse investment experience brings valuable insight and perspective to our board at a time when we are experiencing rapid growth," said Richard MacKay, chairman. "We look forward to benefiting from their contribution and guidance as Valeo continues to develop as a leading Canadian pharmaceutical company."

Ms. Close is a senior investment and environmental, social and governance (ESG) professional with over 25 years of experience in capital markets, with roles spanning sell-side trading and institutional sales to buy-side research, risk management and strategy. She is the founder and managing partner of Close Group Consulting, an independent, boutique ESG advisory firm headquartered in Montreal, with offices in Toronto, Boston and London (United Kingdom). Ms. Close is a sought-after speaker and regularly publishes ESG thought leadership and research. Ms. Close holds an MSc finance from Concordia University with a BA economics from McGill University and is a chartered financial analyst (CFA).

Didier Leconte is a highly experienced investor and Canadian life sciences leader. He has deep commercial experience in Canada and Quebec's technology transfer and investment arenas. With a strong dedication to the development of Quebec's and Canada's life sciences industries, Mr. Leconte served as vice-president, life science and technology, for Investissement Quebec and vice-president life sciences at Fonds de solidarite FTQ. Mr. Leconte holds an MBA, technology management and innovation, from the Universite du Quebec a Montreal, a certification in governance from Universite Laval and an engineering degree in material sciences from Ecole d'ingenieurs Sup Galilee, Institut Galilee, Universite Sorbonne Paris Nord.

About Valeo Pharma Inc.

Valeo Pharma is a fast-growing Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Headquartered in Kirkland, Que., Valeo Pharma has all the required capabilities and the full infrastructure to register and properly manage its growing product portfolio through all stages of commercialization.